Navari, R. M., Binder, G., Molassiotis, A., Roeland, E., Ruddy, K. J., LeBlanc, T. W., … Schwartzberg, L. (2021). Chemotherapy-induced nausea and vomiting (CINV) risk after prior breakthrough CINV: Unmasking the false average. In CANCER RESEARCH (Vol. 81).

Navari, Rudolph M., Gary Binder, Alexander Molassiotis, Eric Roeland, Kathryn J. Ruddy, Thomas W. LeBlanc, Dwight D. Kloth, et al. “Chemotherapy-induced nausea and vomiting (CINV) risk after prior breakthrough CINV: Unmasking the false average.” In CANCER RESEARCH, Vol. 81, 2021.

Navari RM, Binder G, Molassiotis A, Roeland E, Ruddy KJ, LeBlanc TW, et al. Chemotherapy-induced nausea and vomiting (CINV) risk after prior breakthrough CINV: Unmasking the false average. In: CANCER RESEARCH. 2021.

Navari, Rudolph M., et al. “Chemotherapy-induced nausea and vomiting (CINV) risk after prior breakthrough CINV: Unmasking the false average.” CANCER RESEARCH, vol. 81, no. 4, 2021.

Navari RM, Binder G, Molassiotis A, Roeland E, Ruddy KJ, LeBlanc TW, Kloth DD, Sebastiani S, Dimberg LY, Schmerold LM, Liu X, Schwartzberg L. Chemotherapy-induced nausea and vomiting (CINV) risk after prior breakthrough CINV: Unmasking the false average. CANCER RESEARCH. 2021.